| 26th Apr 2019 6:20 pm |
RNS |
Acquisition of further interest in Renalytix AI |
| 26th Apr 2019 5:42 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Apr 2019 12:55 pm |
RNS |
Holding(s) in Company |
| 1st Apr 2019 7:00 am |
RNS |
Publication of confirmation study results |
| 25th Mar 2019 7:00 am |
RNS |
Half-year Report |
| 22nd Mar 2019 7:00 am |
RNS |
RenalytixAI Forms Core Investigator Group |
| 12th Mar 2019 7:00 am |
RNS |
Investor briefing |
| 14th Feb 2019 7:00 am |
RNS |
Appointment of Nomad and Joint Broker |
| 13th Feb 2019 7:00 am |
RNS |
Joint venture partnership agreement with AKESOgen |
| 6th Feb 2019 7:00 am |
RNS |
RenalytixAI Expands Leadership Team |
| 23rd Jan 2019 7:00 am |
RNS |
Initiates Clinical Validation Study |
| 21st Jan 2019 7:00 am |
RNS |
Clarification re. lock-up restrictions |
| 2nd Jan 2019 7:00 am |
RNS |
Exercise of Option for Exclusive License |
| 20th Dec 2018 5:20 pm |
RNS |
Director/PDMR Shareholding |
| 20th Dec 2018 7:01 am |
RNS |
Planned appointment of joint broker & of NOMAD |
| 19th Dec 2018 6:28 pm |
RNS |
Director Dealing |
| 17th Dec 2018 1:30 pm |
RNS |
Holding(s) in Company |
| 9th Nov 2018 10:30 am |
RNS |
Holding(s) in Company |
| 8th Nov 2018 4:50 pm |
RNS |
Holding(s) in Company |
| 8th Nov 2018 7:00 am |
RNS |
Director/PDMR Shareholding |
| 6th Nov 2018 7:00 am |
RNS |
RENX Admission to AIM and First Day of Dealings |
